PAHC

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.84
Percentage change -3.49	%

Peers: ZTS ELAN IDXX NEOG MWG CTLT KMDA MNOV IRWD PTCT

| Held by: IJR IWM VTI AVUV VXF IJT SPSM IWN DWAS DES

Scroll to Statements

Index	RUT	P/E	29.75	EPS (ttm)	0.78	Insider Own	50.12%	Shs Outstand	20.37M	Perf Week	-0.47%
Market Cap	942.40M	Forward P/E	11.57	EPS next Y	2.01	Insider Trans	0.02%	Shs Float	20.22M	Perf Month	36.44%
Income	31.79M	PEG	1.33	EPS next Q	0.52	Inst Own	50.34%	Short Float	4.51%	Perf Quarter	1.22%
Sales	1.19B	P/S	0.79	EPS this Y	52.08%	Inst Trans	0.68%	Short Ratio	3.43	Perf Half Y	-4.95%
Book/sh	6.56	P/B	3.54	EPS next Y	11.00%	ROA	2.77%	Short Interest	0.91M	Perf Year	26.36%
Cash/sh	1.74	P/C	13.40	EPS next 5Y	22.31%	ROE	11.86%	52W Range	16.16 - 26.55	Perf YTD	10.71%
Dividend Est.	0.48 (2.04%)	P/FCF	19.21	EPS past 5Y	-46.42%	ROI	3.15%	52W High	-12.43%	Beta	0.74
Dividend TTM	0.48 (2.06%)	Quick Ratio	1.23	Sales past 5Y	4.34%	Gross Margin	32.51%	52W Low	43.87%	ATR (14)	0.97
Dividend Ex-Date	Jun 04, 2025	Current Ratio	2.91	EPS Y/Y TTM	141.45%	Oper. Margin	10.27%	RSI (14)	61.47	Volatility	2.87% 4.19%
Employees	1940	Debt/Eq	2.89	Sales Y/Y TTM	19.12%	Profit Margin	2.67%	Recom	3.75	Target Price	18.50
Option/Short	Yes / Yes	LT Debt/Eq	2.80	EPS Q/Q	147.30%	Payout	805.37%	Rel Volume	0.62	Prev Close	24.09
Sales Surprise	-1.25%	EPS Surprise	21.04%	Sales Q/Q	32.14%	Earnings	May 07 AMC	Avg Volume	265.78K	Price	23.25
SMA20	9.55%	SMA50	13.84%	SMA200	7.08%	Trades		Volume	163,894	Change	-3.49%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-10-24	Initiated	JP Morgan	Neutral	$22
Dec-07-23	Initiated	Exane BNP Paribas	Underperform	$9
Dec-21-22	Initiated	ROTH Capital	Buy	$18
Jul-25-22	Downgrade	Barclays	Equal Weight → Underweight	$22
Jan-10-22	Upgrade	Barclays	Underweight → Equal Weight	$23
Nov-18-21	Initiated	Morgan Stanley	Equal-Weight	$23
Aug-05-21	Resumed	Credit Suisse	Neutral	$25
Jul-07-21	Downgrade	Barclays	Equal Weight → Underweight	$23
Aug-06-20	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$20
Feb-06-20	Downgrade	Gabelli & Co	Buy → Hold	$30
Jan-28-20	Upgrade	Barclays	Underweight → Equal Weight
Sep-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$21 → $30
Aug-29-19	Reiterated	BofA/Merrill	Underperform	$29 → $18
Jun-11-19	Initiated	Barclays	Underweight	$25
May-23-19	Initiated	Guggenheim	Neutral
May-09-19	Upgrade	Gabelli & Co	Hold → Buy	$42
Aug-23-17	Resumed	BofA/Merrill	Underperform	$33
Jun-02-17	Downgrade	Credit Suisse	Outperform → Neutral
Dec-15-16	Initiated	Piper Jaffray	Overweight
Nov-11-16	Downgrade	Macquarie	Neutral → Underperform

Show Previous Ratings

Today 12:00PM	What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now? (Zacks)
11:36AM	AST Business Growth & Strategic Acquisitions Support STERIS Stock (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:10AM	Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market (Zacks)
07:49AM	What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? (Zacks)
08:53AM	Loading…
May-20-25 08:53AM	Should You Continue to Hold Charles River Stock in Your Portfolio? (Zacks)
08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-19-25 08:38AM	Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally? (Zacks)
May-16-25 07:47AM	Should You Continue to Hold Medtronic Stock in Your Portfolio Now? (Zacks)
06:34AM	Should Edwards Lifesciences Stock Remain in Your Portfolio Now? (Zacks)
May-15-25 08:40AM	STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket (Zacks)
May-14-25 07:11AM	Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? (Zacks) -5.04%
May-13-25 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
09:16AM	International Markets and Phibro (PAHC): A Deep Dive for Investors (Zacks)
07:48AM	Should You Continue to Retain DGX Stock in Your Portfolio? (Zacks)
12:45PM	Loading…
May-12-25 12:45PM	3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks) +9.03%
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
May-09-25 03:25AM	Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... (GuruFocus.com)
May-08-25 08:13AM	Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised (Zacks) +14.75%
May-07-25 08:30PM	Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics (Zacks)
07:40PM	Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates (Zacks)
06:33PM	Phibro: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance (Business Wire)
May-06-25 04:15PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
May-01-25 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-30-25 10:01AM	Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-24-25 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
Apr-23-25 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results (Business Wire)
Apr-22-25 11:25AM	Phibro Animal Health price target lowered to $18 from $22 at BofA (TipRanks)
11:40AM	Loading…
Apr-16-25 11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? (Zacks)
09:35AM	Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks (Zacks)
Apr-11-25 09:35AM	Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks (Zacks)
Apr-10-25 11:36AM	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) -7.03%
Apr-09-25 12:45PM	Here is Why Growth Investors Should Buy Phibro (PAHC) Now (Zacks) +6.60%
08:57AM	Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence (Zacks)
08:39AM	Is it the Right Time to Add EYE Stock to Your Portfolio Now? (Zacks)
Apr-08-25 09:57AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Apr-04-25 08:09AM	Reasons to Add ABT Stock to Your Portfolio Right Now (Zacks) -5.09%
Apr-02-25 07:27AM	Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now? (Zacks)
Mar-31-25 11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? (Zacks)
Mar-28-25 08:56AM	Is Myriad Genetics Stock Worth Holding in Your Portfolio Now? (Zacks)
Mar-27-25 09:07AM	Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock? (Zacks)
09:06AM	Should You Retain Exact Sciences Stock in Your Portfolio Now? (Zacks)
05:00AM	HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-26-25 11:44AM	3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally (Zacks)
09:21AM	Should You Bet on PAHC Stock at a Discounted P/E of 10.41X? (Zacks)
Mar-25-25 08:11AM	Should You Consider Retaining PBH Stock in Your Portfolio Now? (Zacks)
Mar-24-25 12:45PM	Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice (Zacks)
08:09AM	Insulet Gains 62.9% in a Year: What's Driving the Stock? (Zacks)
Mar-21-25 12:15PM	Should You Consider Retaining ZBH Stock in Your Portfolio Now? (Zacks)
Mar-20-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Mar-19-25 11:22AM	Here's Why You Should Retain AMED Stock in Your Portfolio Now (Zacks)
Mar-14-25 09:40AM	Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? (Zacks)
Mar-07-25 11:31AM	Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report? (Zacks)
Mar-05-25 04:00PM	Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference (Business Wire)
Mar-03-25 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks) +7.83%
Feb-26-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) (Zacks)
09:55AM	Bears are Losing Control Over Phibro (PAHC), Here's Why It's a 'Buy' Now (Zacks)
09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
Feb-20-25 04:00PM	Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit (Business Wire)
Feb-14-25 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Feb-11-25 12:00PM	Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know (Zacks)
09:15AM	Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-10-25 12:45PM	Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks) +10.68%
09:40AM	Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? (Zacks)
09:15AM	Phibro (PAHC) Reliance on International Sales: What Investors Need to Know (Zacks)
Feb-07-25 02:14AM	Phibro Animal Health Corp (PAHC) Q2 2025 Earnings Call Highlights: Strong Growth in Animal ... (GuruFocus.com)
Feb-05-25 06:30PM	Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics (Zacks) +9.88%
06:05PM	Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
05:05PM	Phibro: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance (Business Wire)
07:11AM	Phibro Animal Health Corp (PAHC) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-04-25 04:15PM	Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
09:50AM	Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock (Zacks)
07:12AM	Earnings To Watch: Phibro Animal Health Corp (PAHC) Reports Q2 2025 Result (GuruFocus.com)
Feb-03-25 12:00PM	All You Need to Know About Phibro (PAHC) Rating Upgrade to Strong Buy (Zacks)
Jan-29-25 10:00AM	Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy? (Zacks)
09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
Jan-24-25 12:45PM	Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:40AM	Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? (Zacks)
Jan-23-25 04:45PM	Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors (Business Wire)
Jan-22-25 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results (Business Wire)
Jan-13-25 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Jan-08-25 12:45PM	3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks)
09:40AM	Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? (Zacks)
Dec-27-24 09:40AM	Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock (Zacks)
Dec-19-24 02:28PM	Bristol Myers Squibb Stock Earns 83 RS Rating (Investor's Business Daily)
Dec-11-24 09:40AM	Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term (Zacks)
Dec-09-24 09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
Dec-06-24 11:31AM	Phibro (PAHC) Down 2.5% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-29-24 12:45PM	Here is Why Growth Investors Should Buy Phibro (PAHC) Now (Zacks)
Nov-26-24 09:50AM	Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-21-24 09:40AM	Should Value Investors Buy Phibro Animal Health (PAHC) Stock? (Zacks)
Nov-12-24 12:45PM	Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice (Zacks)
09:15AM	Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-11-24 09:15AM	Investing in Phibro (PAHC)? Don't Miss Assessing Its International Revenue Trends (Zacks) +7.13%

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BFI Co., LLC	10% Owner	May 19 '25	Proposed Sale	24.00	241,129	5,787,096		May 19 05:25 PM
CORCORAN E THOMAS	Director	Feb 24 '25	Buy	22.10	5,000	110,500	30,000	Feb 26 04:15 PM
BFI Co., LLC	10% Owner	Feb 18 '25	Proposed Sale	25.77	247,769	6,385,007		Feb 18 05:35 PM
CORCORAN E THOMAS	Director	Sep 04 '24	Buy	20.02	5,000	100,100	25,000	Sep 06 04:34 PM
BFI Co., LLC	10% Owner	Aug 13 '24	Proposed Sale	17.29	257,400	4,450,446		Aug 13 05:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Phibro Animal Health Corp

Upgrade your FINVIZ experience